Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08ISP
|
||||
Former ID |
DNC005007
|
||||
Drug Name |
5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527210] | ||
Structure |
Download2D MOL |
||||
Formula |
C8H16N2
|
||||
Canonical SMILES |
CCCC1CC(=NC1C)N
|
||||
InChI |
1S/C8H16N2/c1-3-4-7-5-8(9)10-6(7)2/h6-7H,3-5H2,1-2H3,(H2,9,10)
|
||||
InChIKey |
KBOKLILFNBAIHC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Inhibitor | [527210] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.